Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias-Reference-Cited by-同舟云学术

Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias

Published:2022-11 Issue: Volume:110 Page:102452
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Kfoury Maria^ORCID,Najean Marie,Lappara Ariane,Voisin Anne-Laure,Champiat Stéphane,Michot Jean-Marie,Laghouati Salim,Robert Caroline,Besse Benjamin,Soria Jean-Charles,Lambotte Olivier,Massard Christophe,Marabelle Aurélien,Texier Matthieu

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference25 articles.

1. Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence;Vaddepally;Cancers,2020

2. Das S, Johnson DB. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors. J Immunother Cancer 2019;7. doi:10.1186/s40425-019-0805-8.

3. Eggermont AMM, Kicinski M, Blank CU, et al. Association between immune-related adverse events and recurrence-free survival among patients with stage III melanoma randomized to receive pembrolizumab or placebo: a secondary analysis of a randomized clinical trial. JAMA Oncol Published Online First: 2 January 2020. doi:10.1001/jamaoncol.2019.5570.

4. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes;Freeman-Keller;Clin Cancer Res Off J Am Assoc Cancer Res,2016

5. Association of immune-related adverse events with nivolumab efficacy in non–small-cell lung cancer;Haratani;JAMA Oncol,2018

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors-associated cranial nerves involvement: a systematic literature review on 136 patients;Journal of Neurology;2024-09-03

2. Clinical and Molecular Variables Associated With Early Progression to Checkpoint Inhibitors in MSI-High Metastatic Colorectal Cancer: A Retrospective Cohort Study;Clinical Colorectal Cancer;2024-09

3. Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for oesophageal squamous cell carcinoma: insights from the EC-CRT-001 phase II trial;eClinicalMedicine;2024-09

4. Association of Immune-Related Adverse Events and the Efficacy of Anti–PD-(L)1 Monotherapy in Non–Small Cell Lung Cancer: Adjusting for Immortal-Time Bias;Cancer Research and Treatment;2024-07-15

5. Impact of immunosuppressive agents on the management of immune-related adverse events of immune checkpoint blockers;European Journal of Cancer;2024-06